Zions Bancorporation’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.93M | Buy |
47,930
+25,405
| +113% | +$3.94M | 0.44% | 37 |
|
|
2024
Q3 | $3.65M | Buy |
22,525
+19,604
| +671% | +$3.12M | 0.27% | 83 |
|
|
2024
Q2 | $427K | Sell |
2,921
-1,072
| -27% | -$159K | 0.03% | 254 |
|
|
2024
Q1 | $632K | Sell |
3,993
-274
| -6% | -$43.6K | 0.05% | 239 |
|
|
2023
Q4 | $669K | Sell |
4,267
-147
| -3% | -$22.5K | 0.05% | 234 |
|
|
2023
Q3 | $687K | Sell |
4,414
-1,022
| -19% | -$169K | 0.06% | 221 |
|
|
2023
Q2 | $900K | Buy |
5,436
+408
| +8% | +$65.8K | 0.08% | 200 |
|
|
2023
Q1 | $779K | Sell |
5,028
-968
| -16% | -$156K | 0.07% | 214 |
|
|
2022
Q4 | $1.06M | Sell |
5,996
-700
| -10% | -$121K | 0.08% | 154 |
|
|
2022
Q3 | $1.09M | Sell |
6,696
-1,274
| -16% | -$216K | 0.11% | 130 |
|
|
2022
Q2 | $1.42M | Sell |
7,970
-1,178
| -13% | -$210K | 0.14% | 112 |
|
|
2022
Q1 | $1.62M | Buy |
9,148
+2,832
| +45% | +$482K | 0.15% | 98 |
|
|
2021
Q4 | $1.08M | Sell |
6,316
-99
| -2% | -$16.2K | 0.1% | 131 |
|
|
2021
Q3 | $1.04M | Buy |
6,415
+758
| +13% | +$129K | 0.11% | 110 |
|
|
2021
Q2 | $932K | Buy |
5,657
+190
| +3% | +$31.5K | 0.09% | 114 |
|
|
2021
Q1 | $898K | Sell |
5,467
-580
| -10% | -$93.8K | 0.1% | 96 |
|
|
2020
Q4 | $952K | Sell |
6,047
-504
| -8% | -$74.4K | 0.12% | 83 |
|
|
2020
Q3 | $975K | Sell |
6,551
-11
| -0.2% | -$1.63K | 0.14% | 74 |
|
|
2020
Q2 | $923K | Sell |
6,562
-142
| -2% | -$20.7K | 0.13% | 71 |
|
|
2020
Q1 | $879K | Sell |
6,704
-3,784
| -36% | -$537K | 0.15% | 67 |
|
|
2019
Q4 | $1.53M | Sell |
10,488
-6,777
| -39% | -$919K | 0.22% | 44 |
|
|
2019
Q3 | $2.23M | Sell |
17,265
-2,908
| -14% | -$383K | 0.32% | 31 |
|
|
2019
Q2 | $2.81M | Buy |
20,173
+73
| +0.4% | +$10.1K | 0.41% | 20 |
|
|
2019
Q1 | $2.81M | Buy |
+20,100
| New | +$2.69M | 0.45% | 21 |
|
|
2018
Q4 | – | Sell |
-25,995
| Closed | -$3.59M | – | 637 |
|
|
2018
Q3 | $3.59M | Buy |
+25,995
| New | +$3.45M | 0.85% | 11 |
|
|
2018
Q2 | – | Sell |
-54,329
| Closed | -$6.96M | – | 581 |
|
|
2018
Q1 | $6.96M | Sell |
54,329
-2,880
| -5% | -$389K | 1.52% | 10 |
|
|
2017
Q4 | $7.99M | Sell |
57,209
-2,114
| -4% | -$294K | 1.37% | 13 |
|
|
2017
Q3 | $7.71M | Buy |
59,323
+726
| +1% | +$96.2K | 1.11% | 15 |
|
|
2017
Q2 | $7.75M | Buy |
58,597
+32,354
| +123% | +$4.13M | 1.33% | 17 |
|
|
2017
Q1 | $3.27M | Sell |
26,243
-7,662
| -23% | -$915K | 0.62% | 17 |
|
|
2016
Q4 | $3.91M | Sell |
33,905
-1,259
| -4% | -$145K | 0.69% | 18 |
|
|
2016
Q3 | $4.16M | Sell |
35,164
-1,298
| -4% | -$157K | 0.79% | 18 |
|
|
2016
Q2 | $4.46M | Buy |
36,462
+1,357
| +4% | +$154K | 0.78% | 19 |
|
|
2016
Q1 | $3.9M | Sell |
35,105
-7,215
| -17% | -$747K | 0.7% | 18 |
|
|
2015
Q4 | $4.28M | Buy |
42,320
+6,300
| +17% | +$634K | 0.75% | 22 |
|
|
2015
Q3 | $3.52M | Sell |
36,020
-20,178
| -36% | -$1.95M | 0.65% | 20 |
|
|
2015
Q2 | $5.48M | Buy |
56,198
+16,747
| +42% | +$1.68M | 0.87% | 20 |
|
|
2015
Q1 | $3.97M | Buy |
+39,451
| New | +$4.01M | 0.68% | 22 |
|
Other funds holding JNJ
Zions Bancorporation's JNJ Position: Q4 2024 in Review
Zions Bancorporation increased its Johnson & Johnson (JNJ) stake by 113% in Q4 2024, buying an estimated $3.94M and bringing the position to 47,930 shares worth $6.93M. The position accounts for 0.44% of the portfolio, ranked #37.
Zions Bancorporation first reported a position in JNJ in Q1 2015 and has held it in 38 quarters since. The position peaked at $7.99M in Q4 2017. 4,105 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.
- Zions Bancorporation held 47,930 shares of Johnson & Johnson worth $6.93M as of Q4 2024.
- Zions Bancorporation bought 25,405 Johnson & Johnson shares in Q4 2024, an estimated $3.94M.
- Johnson & Johnson made up 0.44% of Zions Bancorporation's portfolio in Q4 2024, its #37 holding.
- Zions Bancorporation first reported a position in Johnson & Johnson in Q1 2015 and has held it in 38 quarters since.
- Zions Bancorporation's Johnson & Johnson position peaked at $7.99M in Q4 2017.
- 4,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.